News
During a talk at the recent Jefferies Global Healthcare Conference, Cogent CEO Andy Robbins said Blueprint Medicines’ Ayvakit ...
The death of a boy with Duchenne muscular dystrophy, tied to a gene therapy, is above all a tragedy. But it is also ...
Gilead's CEO says he's committed to making sure people around the world can get his firm's new HIV prevention shot Yeztugo.
Emotionally intelligent AI can generate trust, motivate action, elevate the relationship between patients and their care ...
New brain-computer interface reduced time lag in translating thoughts into speech in a meaningful advance for the field.
Two advocates demand systemic change in addiction treatment that prioritizes safety and accountability above all else.
A new twice-yearly shot could be a "game changer" in the fight against AIDS, but experts' hopes have dimmed because of the ...
Gilead has won FDA approval for an HIV prevention shot that is administered only once every six months. When will low-income ...
Tennessee’s ban on gender-affirming care for minors can stand after the Supreme Court ruled that it does not constitute ...
Vinay Prasad is taking on several big roles at the FDA, solidifying his position as a top adviser to Commissioner Marty ...
The latest from the BIO 2025 conference: more universities open to private equity deals, emerging companies turn to new ...
The updated agenda for the Advisory Committee on Immunization Practices comes a week after Kennedy announced he had dismissed ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results